Predictors of Olfactory Decline in Aging: A Longitudinal Population-Based Study.
Cognitive aging
Epidemiology
Olfactory
Olfactory impairment
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
13 11 2020
13 11 2020
Historique:
received:
25
06
2020
pubmed:
5
9
2020
medline:
23
2
2021
entrez:
4
9
2020
Statut:
ppublish
Résumé
Olfactory dysfunction is common in aging and associated with dementia and mortality. However, longitudinal studies tracking change in olfactory ability are scarce. We sought to identify predictors of interindividual differences in rate of olfactory identification change in aging. Participants were 1780 individuals, without dementia at baseline and with at least 2 olfactory assessments over 12 years of follow-up (mean age = 70.5 years; 61.9% female), from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K). Odor identification was assessed with the Sniffin' Sticks. We estimated the impact of demographic, health, and genetic factors on rate of olfactory change with linear mixed effect models. Advancing age, manufacturing profession, history of cerebrovascular disease, higher cardiovascular disease burden, diabetes, slower walking speed, higher number of medications, and the APOE ε4 allele were associated with accelerated odor identification decline (ps < .014). Multi-adjusted analyses showed unique associations of age, diabetes, and ε4 to olfactory decline (ps < .017). In 1531 participants who remained free of dementia (DSM IV criteria) during follow-up, age, cardiovascular disease burden, and diabetes were associated with accelerated decline (ps < .011). Of these, age and diabetes remained statistically significant in the multi-adjusted model (ps < .001). Demographic, vascular, and genetic factors are linked to rate of decline in odor identification in aging. Although some olfactory loss may be an inevitable part of aging, our results highlight the importance of vascular factors for the integrity of the olfactory system, even in the absence of dementia.
Sections du résumé
BACKGROUND
Olfactory dysfunction is common in aging and associated with dementia and mortality. However, longitudinal studies tracking change in olfactory ability are scarce. We sought to identify predictors of interindividual differences in rate of olfactory identification change in aging.
METHOD
Participants were 1780 individuals, without dementia at baseline and with at least 2 olfactory assessments over 12 years of follow-up (mean age = 70.5 years; 61.9% female), from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K). Odor identification was assessed with the Sniffin' Sticks. We estimated the impact of demographic, health, and genetic factors on rate of olfactory change with linear mixed effect models.
RESULTS
Advancing age, manufacturing profession, history of cerebrovascular disease, higher cardiovascular disease burden, diabetes, slower walking speed, higher number of medications, and the APOE ε4 allele were associated with accelerated odor identification decline (ps < .014). Multi-adjusted analyses showed unique associations of age, diabetes, and ε4 to olfactory decline (ps < .017). In 1531 participants who remained free of dementia (DSM IV criteria) during follow-up, age, cardiovascular disease burden, and diabetes were associated with accelerated decline (ps < .011). Of these, age and diabetes remained statistically significant in the multi-adjusted model (ps < .001).
CONCLUSION
Demographic, vascular, and genetic factors are linked to rate of decline in odor identification in aging. Although some olfactory loss may be an inevitable part of aging, our results highlight the importance of vascular factors for the integrity of the olfactory system, even in the absence of dementia.
Identifiants
pubmed: 32886741
pii: 5901599
doi: 10.1093/gerona/glaa221
pmc: PMC7662159
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2441-2449Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America.
Références
Acta Neuropathol Commun. 2018 Feb 23;6(1):14
pubmed: 29471869
JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):728-34
pubmed: 23868430
Chem Senses. 2015 Mar;40(3):173-9
pubmed: 25550307
Laryngoscope. 2004 Oct;114(10):1764-9
pubmed: 15454769
Neurobiol Aging. 2011 Dec;32(12):2254-65
pubmed: 20079556
Future Cardiol. 2016 Mar;12(2):237-48
pubmed: 26919226
Aging Clin Exp Res. 2020 Jun;32(6):1007-1016
pubmed: 31471890
Front Neurosci. 2020 Feb 21;14:140
pubmed: 32153360
PLoS One. 2011;6(11):e27801
pubmed: 22110763
J Alzheimers Dis. 2005 Apr;7(2):149-57; discussion 173-80
pubmed: 15851853
J Am Geriatr Soc. 2017 Jun;65(6):1238-1243
pubmed: 28326534
Front Aging Neurosci. 2010 Jun 07;2:24
pubmed: 20589104
Endocr Metab Immune Disord Drug Targets. 2020;20(2):198-212
pubmed: 31203811
Front Psychol. 2019 Feb 13;10:242
pubmed: 30814965
Chem Senses. 2014 Mar;39(3):185-94
pubmed: 24429163
Rhinology. 2018 Dec 1;56(4):351-357
pubmed: 29938715
J Biomed Sci. 2013 Jul 12;20:49
pubmed: 23845000
J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):831-7
pubmed: 26707381
Neurology. 2015 Jan 13;84(2):182-9
pubmed: 25471394
Ann Occup Environ Med. 2018 Mar 12;30:18
pubmed: 29564141
PLoS One. 2014 Oct 01;9(10):e107541
pubmed: 25271633
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1435-41
pubmed: 26253908
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43
pubmed: 17021776
J Gerontol A Biol Sci Med Sci. 2017 Aug 1;72(8):1072-1079
pubmed: 28444135
Front Psychol. 2014 Feb 07;5:20
pubmed: 24570664
Diabetes Care. 2019 Feb;42(2):232-239
pubmed: 30523030
Genes Brain Behav. 2008 Jun;7(4):411-7
pubmed: 17973920
Age Ageing. 2015 Sep;44(5):878-82
pubmed: 26082178
Sci Rep. 2017 Apr 28;7(1):1286
pubmed: 28455505
J Immunol Res. 2019 Feb 20;2019:3128231
pubmed: 30915369
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):719-728
pubmed: 30554358
Lancet. 2008 May 24;371(9626):1800-9
pubmed: 18502305
JAMA. 2002 Nov 13;288(18):2307-12
pubmed: 12425708
J Gerontol B Psychol Sci Soc Sci. 2000 Sep;55(5):P304-10
pubmed: 10985295
Nat Neurosci. 2020 Mar;23(3):323-326
pubmed: 32066986
J Occup Med Toxicol. 2018 Sep 4;13:28
pubmed: 30202422
Eur J Clin Pharmacol. 2015 Apr;71(4):461-71
pubmed: 25666029
J Gerontol A Biol Sci Med Sci. 1996 Mar;51(2):M86-91
pubmed: 8612109
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
Neurobiol Aging. 2016 Feb;38:118-126
pubmed: 26827650
Diabet Med. 2018 Jan;35(1):41-52
pubmed: 29108100
Hypertension. 2016 Dec;68(6):e67-e94
pubmed: 27977393
Chem Senses. 2019 Jan 29;44(2):105-112
pubmed: 30544138
Neurology. 2013 Jul 23;81(4):379-82
pubmed: 23794685
Lancet. 1999 Sep 11;354(9182):919-20
pubmed: 10489957
Int Forum Allergy Rhinol. 2019 Sep;9(9):977-985
pubmed: 31365791
J Int Neuropsychol Soc. 2014 Feb;20(2):209-17
pubmed: 24451436
Neurobiol Aging. 2010 Apr;31(4):567-77
pubmed: 18619712